Labcorp Holdings Operating Income Growth & History (LH)
Labcorp Holdings's operating income was $1.38B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.38B | $298.0M | +27.42% |
| 2024 | 2024-12-31 | $1.09B | $361.1M | +49.77% |
| 2023 | 2023-12-31 | $725.6M | −$710.9M | −49.49% |
| 2022 | 2022-12-31 | $1.44B | −$1.61B | −52.88% |
| 2021 | 2021-12-31 | $3.05B | $603.2M | +24.67% |
| 2020 | 2020-12-31 | $2.45B | $1.12B | +83.84% |
| 2019 | 2019-12-31 | $1.33B | $4.5M | +0.34% |
| 2018 | 2018-12-31 | $1.33B | $20.5M | +1.57% |
| 2017 | 2017-12-31 | $1.31B | $34.6M | +2.72% |
| 2016 | 2016-12-31 | $1.27B | $273.8M | +27.47% |
| 2015 | 2015-12-31 | $996.8M | $86.4M | +9.49% |
| 2014 | 2014-12-31 | $910.4M | −$80.5M | −8.12% |
| 2013 | 2013-12-31 | $990.9M | −$32.6M | −3.19% |
| 2012 | 2012-12-31 | $1.02B | $75.1M | +7.92% |
| 2011 | 2011-12-31 | $948.4M | −$30.4M | −3.11% |
| 2010 | 2010-12-31 | $978.8M | $42.9M | +4.58% |
| 2009 | 2009-12-31 | $935.9M | $93.0M | +11.03% |
| 2008 | 2008-12-31 | $842.9M | $65.9M | +8.48% |
| 2007 | 2007-12-31 | $777.0M | — | — |
Labcorp Holdings quarterly operating income
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $451.6M | $57.1M | +14.47% |
| Q1 2026 | 2026-03-31 | $380.8M | $54.8M | +16.81% |
| Q4 2025 | 2025-12-31 | $267.6M | $51.1M | +23.60% |
| Q3 2025 | 2025-09-30 | $396.6M | $142.5M | +56.08% |
| Q2 2025 | 2025-06-30 | $394.5M | $99.7M | +33.82% |
| Q1 2025 | 2025-03-31 | $326.0M | $4.7M | +1.46% |
| Q4 2024 | 2024-12-31 | $216.5M | $339.3M | — |
| Q3 2024 | 2024-09-30 | $254.1M | $1.8M | +0.71% |
| Q2 2024 | 2024-06-30 | $294.8M | $28.5M | +10.70% |
| Q1 2024 | 2024-03-31 | $321.3M | −$8.5M | −2.58% |
| Q4 2023 | 2023-12-31 | −$122.8M | −$68.6M | — |
| Q3 2023 | 2023-09-30 | $252.3M | −$121.7M | −32.54% |
| Q2 2023 | 2023-06-30 | $266.3M | −$162.5M | −37.90% |
| Q1 2023 | 2023-03-31 | $329.8M | −$358.1M | −52.06% |
| Q4 2022 | 2022-12-31 | −$54.2M | −$573.9M | — |
| Q3 2022 | 2022-09-30 | $374.0M | −$392.9M | −51.23% |
| Q2 2022 | 2022-06-30 | $428.8M | −$275.3M | −39.10% |
| Q1 2022 | 2022-03-31 | $687.9M | −$370.0M | −34.97% |
| Q4 2021 | 2021-12-31 | $519.7M | −$773.5M | −59.81% |
| Q3 2021 | 2021-09-30 | $766.9M | −$280.2M | −26.76% |
| Q2 2021 | 2021-06-30 | $704.1M | $406.4M | +136.51% |
| Q1 2021 | 2021-03-31 | $1.06B | $1.25B | — |
| Q4 2020 | 2020-12-31 | $1.29B | $956.8M | +284.42% |
| Q3 2020 | 2020-09-30 | $1.05B | $707.2M | +208.06% |
| Q2 2020 | 2020-06-30 | $297.7M | −$38.0M | −11.32% |
| Q1 2020 | 2020-03-31 | −$192.6M | −$510.8M | — |
| Q4 2019 | 2019-12-31 | $336.4M | $28.7M | +9.33% |
| Q3 2019 | 2019-09-30 | $339.9M | −$3.5M | −1.02% |
| Q2 2019 | 2019-06-30 | $335.7M | −$33.5M | −9.07% |
| Q1 2019 | 2019-03-31 | $318.2M | $12.8M | +4.19% |
| Q4 2018 | 2018-12-31 | $307.7M | −$22.9M | −6.93% |
| Q3 2018 | 2018-09-30 | $343.4M | $16.7M | +5.11% |
| Q2 2018 | 2018-06-30 | $369.2M | $39.4M | +11.95% |
| Q1 2018 | 2018-03-31 | $305.4M | −$12.7M | −3.99% |
| Q4 2017 | 2017-12-31 | $330.6M | $49.0M | +17.40% |
| Q3 2017 | 2017-09-30 | $326.7M | $2.7M | +0.83% |
| Q2 2017 | 2017-06-30 | $329.8M | −$35.7M | −9.77% |
| Q1 2017 | 2017-03-31 | $318.1M | $18.6M | +6.21% |
| Q4 2016 | 2016-12-31 | $281.6M | $48.6M | +20.86% |
| Q3 2016 | 2016-09-30 | $324.0M | $15.9M | +5.16% |
| Q2 2016 | 2016-06-30 | $365.5M | $42.2M | +13.05% |
| Q1 2016 | 2016-03-31 | $299.5M | $167.1M | +126.21% |
| Q4 2015 | 2015-12-31 | $233.0M | $715.0M | — |
| Q3 2015 | 2015-09-30 | $308.1M | $66.7M | +27.63% |
| Q2 2015 | 2015-06-30 | $323.3M | $76.6M | +31.05% |
| Q1 2015 | 2015-03-31 | $132.4M | −$771.9M | −85.36% |
| Q4 2014 | 2014-12-31 | −$482.0M | −$697.0M | — |
| Q3 2014 | 2014-09-30 | $241.4M | −$3.2M | −1.31% |
| Q2 2014 | 2014-06-30 | $246.7M | −$22.6M | −8.39% |
| Q1 2014 | 2014-03-31 | $904.3M | $642.3M | +245.15% |
| Q4 2013 | 2013-12-31 | $215.0M | −$300,000 | −0.14% |
| Q3 2013 | 2013-09-30 | $244.6M | −$500,000 | −0.20% |
| Q2 2013 | 2013-06-30 | $269.3M | −$6.7M | −2.43% |
| Q1 2013 | 2013-03-31 | $262.0M | −$25.1M | −8.74% |
| Q4 2012 | 2012-12-31 | $215.3M | −$32.2M | −13.01% |
| Q3 2012 | 2012-09-30 | $245.1M | $5.7M | +2.38% |
| Q2 2012 | 2012-06-30 | $276.0M | $50.3M | +22.29% |
| Q1 2012 | 2012-03-31 | $287.1M | $51.3M | +21.76% |
| Q4 2011 | 2011-12-31 | $247.5M | $8.7M | +3.64% |
| Q3 2011 | 2011-09-30 | $239.4M | $4.1M | +1.74% |
| Q2 2011 | 2011-06-30 | $225.7M | −$44.8M | −16.56% |
| Q1 2011 | 2011-03-31 | $235.8M | $1.6M | +0.68% |
| Q4 2010 | 2010-12-31 | $238.8M | $23.0M | +10.66% |
| Q3 2010 | 2010-09-30 | $235.3M | $400,000 | +0.17% |
| Q2 2010 | 2010-06-30 | $270.5M | $25.8M | +10.54% |
| Q1 2010 | 2010-03-31 | $234.2M | −$6.3M | −2.62% |
| Q4 2009 | 2009-12-31 | $215.8M | — | — |
| Q3 2009 | 2009-09-30 | $234.9M | $32.7M | +16.17% |
| Q2 2009 | 2009-06-30 | $244.7M | $49.5M | +25.36% |
| Q1 2009 | 2009-03-31 | $240.5M | — | — |
| Q3 2008 | 2008-09-30 | $202.2M | — | — |
| Q2 2008 | 2008-06-30 | $195.2M | — | — |
Labcorp Holdings operating income trends
Over the last five fiscal years, Labcorp Holdings's operating income decreased from $2.45B to $1.38B, a change of −$1.06B. The latest reported quarter, Q2 2026, shows $451.6M.
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...